Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous adipose-derived mesenchymal stromal cells (Mayo Clinic, f11030)
- Development stage
- Unknown
- Lead developer
- Mayo Clinic
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
An investigational autologous cell therapy developed by the Mayo Clinic to prevent biliary complications, such as strictures and leaks, in recipients of living donor liver transplantation (LDLT). The therapy involves harvesting mesenchymal stromal cells (MSCs) from the patient's own adipose tissue, followed by isolation and culture expansion. During the transplant procedure, the cells are applied directly to the biliary anastomosis site, typically via a cell-seeded mesh or suspension. The treatment utilizes the angiogenic, anti-fibrotic, and immunomodulatory properties of MSCs to enhance healing and reduce the incidence of post-operative biliary issues.
- Other names
- autologous adipose-derived mesenchymal stem cellsAdipose-derived autologous mesenchymal stromal cells
Beyond the preview
Go deeper on autologous adipose-derived mesenchymal stromal cells (Mayo Clinic, f11030).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous adipose-derived mesenchymal stromal cells (Mayo Clinic, f11030).